Clinical Trial Update: Study of Alagebrium in Patients With Insulin-Dependent Type 1 Diabetes and Microalbuminuria [Phase 2]

View source ↗

Summary

A Phase 2 study of alagebrium in insulin-dependent Type 1 diabetes with microalbuminuria was terminated; the update notes the trial status but provides no resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 1 Diabetes Mellitus

Drugs mentioned

• Alagebrium (alagebrium)

Snippet

Sponsor: Synvista Therapeutics, Inc | Conditions: Diabetes Mellitus, Type 1, Diabetic Nephropathy | Phase 2 | Status: TERMINATED